Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00006747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03282396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00003311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03295240. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05495464. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04566887. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04802590. IPD Sharing: NO. Countries: 3. Publications: 0.
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06839053. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
ClinicalTrials.gov study NCT06788652. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients
ClinicalTrials.gov study NCT06255704. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT02455297. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CART-19 Immunotherapy in Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02081937. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04918940. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05951959. IPD Sharing: UNDECIDED. Countries: 7. Publications: 0.
BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03836768. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06572618. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT03153202. IPD Sharing: NO. Countries: 1. Publications: 0.
RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00081874. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00119730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma
ClinicalTrials.gov study NCT00946374. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.